Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague

This publication has 18 references indexed in Scilit:

• The V‐antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation
  Molecular Microbiology, 1999
• Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine
  Vaccine, 1998
• V antigen ofYersinia pestisinhibits neutrophil chemotaxis
  Microbial Pathogenesis, 1998
• Yersinia pestis--etiologic agent of plague
  Clinical Microbiology Reviews, 1997
• A new improved sub-unit vaccine for plague: the basis of protection
  FEMS Immunology & Medical Microbiology, 1995
• Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens
  Clinical Microbiology Reviews, 1992
• The Yersinia pestis V antigen is a regulatory protein necessary for Ca2(+)-dependent growth and maximal expression of low-Ca2+ response virulence genes
  Journal of Bacteriology, 1991
• Plague Immunization. V. Indirect Evidence for the Efficacy of Plague Vaccine
  The Journal of Infectious Diseases, 1974
• Plague Immunization, II. Relation of Adverse Clinical Reactions to Multiple Immunizations with Killed Vaccine
  The Journal of Infectious Diseases, 1974
• Pneumonic plague in an untreated plague-vaccinated individual
  Published by American Medical Association (AMA) ,1967